Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with ...
Scientists uncovered the hidden genes and enzymes tobacco plants use to make nicotine, solving a mystery that lasted more ...
The company's closed-loop platform is designed to dramatically speed up enzyme development for pharmaceuticals, sustainable ...
Imperagen, a Manchester-based techbio company, has closed a £5m seed funding round led by PXN Ventures with participation ...
Morning Overview on MSN
Scientists just flagged an enzyme called IDOL as a powerful new Alzheimer’s target — one that controls how the brain handles toxic cholesterol
Nearly seven million Americans are living with Alzheimer’s disease, and the handful of treatments approved in recent years ...
A mum from west Hull has spoken poignantly of her rainbow baby who she now knows she is likely to lose when he is around ...
Background Interstitial lung disease (ILD) is a major pulmonary complication of idiopathic inflammatory myopathy (IIM), where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results